ESAR - European Surveillance of Antibiotic Resistance
All in-patients; infection and discipline known; 1999 and 2000
Documentation of treatment and outcome

  Total Outcome Treatment Outcome & Treatment
Missing Documented Missing Documented Missing Documented
N N % N % N % N % N % N %
Infection 80 62 77.50 18 22.50 28 35.00 52 65.00 66 82.50 14 17.50
FUO
Respiratory Tract 1014 676 66.67 338 33.33 472 46.55 542 53.45 833 82.15 181 17.85
Sepsis/ Septic Shock 68 46 67.65 22 32.35 14 20.59 54 79.41 49 72.06 19 27.94
Urinary tract infection 1544 1198 77.59 346 22.41 953 61.72 591 38.28 1403 90.87 141 9.13
Intra-abdominal infection 175 154 88.00 21 12.00 85 48.57 90 51.43 164 93.71 11 6.29
Skin/ soft Tissue 500 332 66.40 168 33.60 305 61.00 195 39.00 426 85.20 74 14.80
Wound infection 607 393 64.74 214 35.26 341 56.18 266 43.82 521 85.83 86 14.17
Positive blood culture 205 144 70.24 61 29.76 115 56.10 90 43.90 186 90.73 19 9.27
Bone-/joint infection 27 22 81.48 5 18.52 10 37.04 17 62.96 24 88.89 3 11.11
multiple 93 49 52.69 44 47.31 9 9.68 84 90.32 49 52.69 44 47.31
Total 4313 3076 71.32 1237 28.68 2332 54.07 1981 45.93 3721 86.27 592 13.73

ESBiC Study Center